FlashFeed

Full text

A trio of Hollywood stars is about to appear in the two biggest movies of the summer. Real-life married couple Tom Holland and Zendaya will reprise their roles as Peter Parker and MJ in Spider-Man: Brand New Day , which is scheduled for release on July 31 . They will also both star in Christopher Nolan 's ambitious historical epic The Odyssey , which is already earning plenty of high praise from first reactions earlier this week . Joining Holland and Zendaya in both The Odyssey and Spider-Man: Brand New Day is Jon Bernthal , who is set to make his MCU feature film debut as Frank Castle, as well as portray King Menelaus of Sparta.

Full text

A company just produced kidney and liver tissue in space for the first time, using a method called bioprinting, which 3D-prints living tissue.

The announcement comes from California-based Auxilium Biotechnologies, whose AMP-1 orbital bioprinter made the breakthrough. The bioprinter used cell and tissue designs from the Wake Forest Institute for Regenerative Medicine in North Carolina.

"The ability to manufacture multiple tissue types alongside clinically relevant medical products highlights both the versatility and scalability of our technology," Auxilium CEO Jacob Koffler said in a statement today (July 9).

Auxilium Biotechnologies successfully bioprinted kidney and liver tissues aboard the International Space Station, marking the first time either tissue type has been manufactured in space. (Image credit: Auxilium Biotechnologies) The experiments took place aboard the International Space Station in June. In addition to bioprinting kidney, liver, and cartilage tissues, the AMP-1 machine also created 28 nerve repair implants. The bioprinted materials returned to Earth on a SpaceX Dragon cargo capsule that splashed down in the Pacific Ocean on June 17.

"Successfully bioprinting living liver and kidney tissue aboard the International Space Station marks an important step forward for regenerative medicine," WFIRM director Anthony Atala said in a statement today (July 9). "The uniform cell distribution achieved aboard the space station points to real possibilities for manufacturing medical devices and tissues in space."

Auxilium Biotechnologies successfully completed the first-ever mission to bioprint both medical implants and biological tissues during a single spaceflight aboard the International Space Station. This image shows a nerve repair implant. (Image credit: Auxilium Biotechnologies) This wasn't the first bioprinting experiment to be conducted on the ISS. For example, in 2018 , Russian cosmonaut Oleg Kononenko tested a machine called the "Bioprinter Organ.Aut," which successfully assembled cartilage cells using a magnetic field.

However, Auxilium’s AMP-1 bioprinter is the first tool that has produced multiple types of tissue in space, as well as the first to make kidney and liver tissue in the final frontier. Auxilium says this flexibility will be important as commercial interests expand manufacturing hubs in space for biotech, healthcare and advanced materials development.

"This mission marks an exciting step forward for in-space biomanufacturing and demonstrates what can be achieved when innovative technology is paired with strong collaboration," Isac Lazarovits, Auxilium's engineering vice president, said in the same statement.

"Demonstrating multiple product classes and meaningful production volume within a single mission is an important milestone as we continue advancing toward routine manufacturing operations in orbit," Lazarovits continued.

Full text

SpaceX’s record-setting IPO gave public investors access to one of the world’s most valuable companies, but not equal voting rights. CEO Elon Musk holds just over 40% of the company’s equity while controlling more than 80% of the vote. IPO adviser Lise Buyer says dual-class shares can protect founders from short-term market pressure, but Harvard Law School’s Lucian Bebchuk warns that SpaceX’s structure goes much further, raising risks around accountability, succession, conflicts of interest, and shareholder value. Some investors, including Danish pension fund AkademikerPension, have already rejected the stock over what they call “catastrophic governance,” turning SpaceX into a test case for how much control public markets are willing to give superstar founders. (Source: Bloomberg)